Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September, 2025, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consider and discuss any other routine matter or business of the company.